Resistance to Development of Collagen-Induced Arthritis in C57BL/6 Mice Is Due to a Defect in Secondary, but Not in Primary, Immune Response

Abstract

Collagen-induced arthritis (CIA) is a rodent model of human rheumatoid arthritis. Mice of the H-2q (DBA/1J) background are highly susceptible to disease whereas mice of the H-2b (C57BL/6, B6) background are resistant. To determine why B6 mice are resistant to disease induction, we systematically analyzed T and B cell immune responses in B6 mice, compared to DBA/1J mice, following immunization with bovine type II collagen (CII). We found that both strains showed similar T cell proliferation and cytokine responses and similar levels of anti-CII antibodies (Abs) at day 12 or day 14 of initial immunization (primary immune response), however, those B6 mice that did not develop arthritis showed a significant defect in T cell responses and significantly lower levels of anti-CII Abs following secondary boosting immunization (day 35 of initial immunization, secondary immune response) compared to DBA/1J mice. Our results define for the first time that a defective secondary immune responses in B6 mice leads to the resistance of CIA.

This is a preview of subscription content, access via your institution.

REFERENCES

  1. 1.

    Feldmann M, Brennan FM, Maini RN: Rheumatoid arthritis. Cell 85:307–310, 1996

    PubMed  Google Scholar 

  2. 2.

    Feldmann M: Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2:364–371, 2002

    PubMed  Google Scholar 

  3. 3.

    Feldmann M, Maini RN, Bondeson J, Taylor P, Foxwell BM, Brennan FM: Cytokine blockade in rheumatoid arthritis. Adv Exp Med Biol 490:119–127, 2001

    PubMed  Google Scholar 

  4. 4.

    Trentham DE, Townes AS, Kang AH: Autoimmunity to type II col-lagen an experimental model of arthritis. J Exp Med 146:857–868, 1977

    PubMed  Google Scholar 

  5. 5.

    Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B: Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283:666–668, 1980

    PubMed  Google Scholar 

  6. 6.

    Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, Ogawa T, Hamaoka T, Senoh H, Fujiwara H: Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Im-munol 140:1477–1484, 1988

    Google Scholar 

  7. 7.

    Wooley PH, Luthra HS, Stuart JM, David CS: Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154:688–700, 1981

    PubMed  Google Scholar 

  8. 8.

    Ranges GE, Sriram S, Cooper SM: Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 162:1105–1110, 1985

    PubMed  Google Scholar 

  9. 9.

    Yoshino S, Cleland LG, Mayrhofer G: Treatment of collagen-induced arthritis in rats with a monoclonal antibody against the al-pha/ beta T cell antigen receptor. Arthritis Rheum 34:1039–1047, 1991

    PubMed  Google Scholar 

  10. 10.

    Wooley PH, Luthra HS, Lafuse WP, Huse A, Stuart JM, David CS: Type II collagen-induced arthritis in mice. III. Suppression of arthri-tis by using monoclonal and polyclonal anti-Ia antisera. J Immunol 134:2366–2374, 1985

    PubMed  Google Scholar 

  11. 11.

    Myers LK, Seyer JM, Stuart JM, Terato K, David CS, Kang AH: T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J Immunol 151:500–505, 1993

    PubMed  Google Scholar 

  12. 12.

    Mauri C, Williams RO, Walmsley M, Feldmann M: Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26:1511–1518, 1996

    PubMed  Google Scholar 

  13. 13.

    Svensson L, Jirholt J, Holmdahl R, Jansson L: B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol 111:521–526, 1998

    PubMed  Google Scholar 

  14. 14.

    Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM: Induction of arthritis with monoclonal antibodies to collagen. J Immunol 148:2103–2108, 1992

    PubMed  Google Scholar 

  15. 15.

    Stuart JM, Tomoda K, Yoo TJ, Townes AS, Kang AH: Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum 26:1237–1244, 1983

    PubMed  Google Scholar 

  16. 16.

    Stuart JM, Dixon FJ: Serum transfer of collagen-induced arthritis in mice. J Exp Med 158:378–392, 1983

    PubMed  Google Scholar 

  17. 17.

    Jirholt J, Cook A, Emahazion T, Sundvall M, Jansson L, Nordquist N, Pettersson U, Holmdahl R: Genetic linkage analysis of collagen-induced arthritis in the mouse. Eur J Immunol 28:3321–3328, 1998

    PubMed  Google Scholar 

  18. 18.

    Yang HT, Jirholt J, Svensson L, Sundvall M, Jansson L, Pettersson U, Holmdahl R: Identification of genes controlling collagen-induced arthritis in mice: Striking homology with susceptibility loci previ-ously identified in the rat. J Immunol 163:2916–2921, 1999

    PubMed  Google Scholar 

  19. 19.

    McIndoe RA, Bohlman B, Chi E, Schuster E, Lindhardt M, Hood L: Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. Proc Natl Acad Sci USA 96:2210–2214, 1999

    PubMed  Google Scholar 

  20. 20.

    Guedez YB, Whittington KB, Clayton JL, Joosten LA, van de Loo FA, van den Berg WB, Rosloniec EF: Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and en-ables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 44:2413–2424, 2001

    PubMed  Google Scholar 

  21. 21.

    Yuasa T, Kubo S, Yoshino T, Ujike A, Matsumura K, Ono M, Ravetch JV, Takai T: Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med 189:187–194, 1999

    PubMed  Google Scholar 

  22. 22.

    Wang Y, Kristan J, Hao L, Lenkoski CS, Shen Y, Matis LA: A role for complement in antibody-mediated inflammation: C5-deficient DBA/1 mice are resistant to collagen-induced arthritis. J Immunol 164:4340–4347, 2000

    PubMed  Google Scholar 

  23. 23.

    Yin Z, Zhang DH, Welte T, Bahtiyar G, Jung S, Liu L, Fu XY, Ray A, Craft J: Dominance of IL-12 over IL-4 in gamma delta T cell differentiation leads to default production of IFN-gamma: Failure to down-regulate IL-12 receptor beta 2-chain expression. J Immunol 164:3056–3064, 2000

    PubMed  Google Scholar 

  24. 24.

    Brand DD, Myers LK, Terato K, Whittington KB, Stuart JM, Kang AH, Rosloniec EF: Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1(II)-CB11 in H-2q mice. J Immunol 152:3088–3097, 1994

    PubMed  Google Scholar 

  25. 25.

    Yin Z, Bahtiyar G, Zhang N, Liu L, Zhu P, Robert ME, McNiff J, Madaio MP, Craft J: IL-10 regulates murine lupus. J Immunol 169:2148–2155, 2002

    PubMed  Google Scholar 

  26. 26.

    Watson WC, Townes AS: Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoanti-body subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med 162:1878–1891, 1985

    PubMed  Google Scholar 

  27. 27.

    Luross JA, Williams NA: The genetic and immunopathological pro-cesses underlying collagen-induced arthritis. Immunology 103:407–416, 2001

    PubMed  Google Scholar 

  28. 28.

    Miyahara H, Myers LK, Rosloniec EF, Brand DD, Seyer JM, Stuart JM, Kang AH: Identification and characterization of a ma-jor tolerogenic T-cell epitope of type II collagen that suppresses arthritis in B10.RIII mice. Immunology 86:110–115, 1995

    PubMed  Google Scholar 

  29. 29.

    Myers LK, Miyahara H, Terato K, Seyer JM, Stuart JM, Kang AH: Collagen-induced arthritis in B10.RIII mice (H-2r): Identification of an arthritogenic T-cell determinant. Immunology 84:509–513, 1995

    PubMed  Google Scholar 

  30. 30.

    Tang B, Brand DD, Chiang TM, Stuart JM, Kang AH, Myers LK, Gumanovskaya ML: Immunogenicity and arthritogenicity of recom-binant CB10 in B10.RIII mice. J Immunol 164:481–487, 2000

    PubMed  Google Scholar 

  31. 31.

    Martin RM, Brady JL, Lew AM: The need for IgG2c specific an-tiserum when isotyping antibodies from C57BL/6 and NOD mice. J Immunol Methods 212:187–192, 1998

    PubMed  Google Scholar 

  32. 32.

    Martin RM, Silva A, Lew AM: The Igh-1 sequence of the non-obese diabetic (NOD) mouse assigns it to the IgG2c isotype. Immuno-genetics 46:167–168, 1997

    Google Scholar 

  33. 33.

    Campbell IK, Hamilton JA, Wicks IP: Collagen-induced arthritis in C57BL/6 (H-2b) mice: New insights into an important disease model of rheumatoid arthritis. Eur J Immunol 30:1568–1575, 2000

    PubMed  Google Scholar 

  34. 34.

    Ortmann R, Smeltz R, Yap G, Sher A, Shevach EM: A heritable defect in IL-12 signaling in B10.Q/J mice. I. In vitro analysis. J Im-munol 166:5712–5719, 2001

    Google Scholar 

  35. 35.

    Lanzavecchia A, Sallusto F: Antigen decoding by T lymphocytes: From synapses to fate determination. Nat Immunol 2:487–492, 2001

    PubMed  Google Scholar 

  36. 36.

    Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Rein-hardt RL, Itano A, Pape KA: In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 19:23–45, 2001

    PubMed  Google Scholar 

  37. 37.

    Yin Z, Siegert S, Neure L, Grolms M, Liu L, Eggens U, Radbruch A, Braun J, Sieper J: The elevated ratio of interferon gamma-/ interleukin-4-positive T cells found in synovial fluid and syn-ovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. Rheumatology (Oxford) 38:1058–1067, 1999

    PubMed  Google Scholar 

  38. 38.

    Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 91:8562–8566, 1994

    PubMed  Google Scholar 

  39. 39.

    Nakae S, Asano M, Horai R, Sakaguchi N, Iwakura Y: IL-1 enhances T cell-dependent antibody production through induction of CD40 ligand and OX40 on T cells. J Immunol 167:90–97, 2001

    PubMed  Google Scholar 

  40. 40.

    Tellander AC, Michaelsson E, Brunmark C, Andersson M: Potent ad-juvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma. J Autoimmun 14:295–302, 2000

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pan, M., Kang, I., Craft, J. et al. Resistance to Development of Collagen-Induced Arthritis in C57BL/6 Mice Is Due to a Defect in Secondary, but Not in Primary, Immune Response. J Clin Immunol 24, 481–491 (2004). https://doi.org/10.1023/B:JOCI.0000040919.16739.44

Download citation

  • Antibodies
  • cellular proliferation
  • immune memory
  • rheumatoid arthritis;
  • Th1/Th2